Progesterone Receptor Negative Recruiting Phase 3 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02445391Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant ChemotherapyTreatment